Nov 5 (Reuters) - ESSA Pharma Inc EPI.TO :
* Receives health Canada approval to commence clinical development for epi-506
* Says enrolment in the clinical trial in Canada is expected to commence in the
next few weeks
* Source text for Eikon urn:newsml:reuters.com:*:nCNW3XSv5a
* Further company coverage EPI.TO